Reply
Ramkiran Cherukuru, Ashwin Rammohan, Mohamed Rela – 8 March 2021
Cancer‐Associated Fibroblast‐Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma Progression
Mengjia Song, Junyi He, Qiu‐Zhong Pan, Jieying Yang, Jingjing Zhao, Yao‐Jun Zhang, Yue Huang, Yan Tang, Qijing Wang, Jia He, Jiamei Gu, Yongqiang Li, Shiping Chen, Jianxiong Zeng, Zi‐Qi Zhou, Chaopin Yang, Yulong Han, Hao Chen, Tong Xiang, De‐Sheng Weng, Jian‐Chuan Xia – 7 March 2021
A Dynamic Aspartate‐to‐Alanine Aminotransferase Ratio Provides Valid Predictions of Incident Severe Liver Disease
Fredrik Åberg, Christopher J. Danford, Maja Thiele, Mats Talbäck, Ditlev Nytoft Rasmussen, Z. Gordon Jiang, Niklas Hammar, Patrik Nasr, Mattias Ekstedt, Anna But, Pauli Puukka, Aleksander Krag, Jouko Sundvall, Iris Erlund, Veikko Salomaa, Per Stål, Stergios Kechagias, Rolf Hultcrantz, Michelle Lai, Nezam Afdhal, Antti Jula, Satu Männistö, Annamari Lundqvist, Markus Perola, Martti Färkkilä, Hannes Hagström – 7 March 2021 – The aspartate‐to‐alanine aminotransferase ratio (AAR) is associated with liver fibrosis, but its predictive performance is suboptimal.
Metabolomic Analysis Uncovers Energy Supply Disturbance as an Underlying Mechanism of the Development of Alcohol‐Associated Liver Cirrhosis
Ying Huang, Ming Niu, Jing Jing, Zi‐teng Zhang, Xu Zhao, Shuai‐shuai Chen, Shan‐shan Li, Zhuo Shi, Ang Huang, Zheng‐Sheng Zou, Yue‐cheng Yu, Xiao‐he Xiao, Suthat Liangpunsakul, Jia‐bo Wang – 7 March 2021 – Alcohol‐associated liver disease (ALD) is caused by alcohol metabolism’s effects on the liver. The underlying mechanisms from a metabolic view in the development of alcohol‐associated liver cirrhosis (ALC) are still elusive.
Cirrhotic Cardiomyopathy: An Evolving Diagnostic Entity With Long‐Term Clinical Sequelae
Anoop N. Koshy, Paul J. Gow, Omar Farouque – 7 March 2021
Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development
Yuh‐Jin Liang, Wei Teng, Chih‐Li Chen, Cheng‐Pu Sun, Rui‐Dung Teng, Yen‐Hua Huang, Kung‐Hao Liang, Yi‐Wen Chen, Chung‐Chih Lin, Chien‐Wei Su, Mi‐Hua Tao, Jaw‐Ching Wu – 4 March 2021
Macrophage Heterogeneity in NASH: More Than Just Nomenclature
Gopanandan Parthasarathy, Harmeet Malhi – 4 March 2021
Letter to the Editor: Recognizing Significant Role of Neoadjuvant Radiotherapy for HCC With Vascular Invasion
Xiu‐Ping Zhang, Guo‐Dong Zhao, Qu Liu, Rong Liu – 4 March 2021
Letter to the Editor: Restructuring the Gut Microbiota of Patients with Cirrhosis After HCV Eradication: A Matter of Time?
Francesca Romana Ponziani, Antonio Gasbarrini, Maurizio Pompili – 4 March 2021
COVID‐19 Aftershocks on Alcohol‐Associated Liver Disease: An Early Cross‐Sectional Report From the U.S. Epicenter
Stephanie M. Rutledge, Thomas D. Schiano, Sander Florman, Gene Y. Im – 4 March 2021 – Experts have forewarned about the coronavirus disease 2019 (COVID‐19) pandemic environment fomenting the rising incidence of alcohol use disorder (AUD) and alcohol‐associated liver disease (ALD). We performed a cross‐sectional study of ALD at our liver transplantation (LT) center, located in the initial U.S. epicenter, New York City.